LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged patent ineligible subject matter · clear

Federal Circuit

USPTO Guidance Cannot Modify or Supplant the Alice/Mayo Framework

IN RE: CHRISTOPHER JOHN RUDY Before Prost, O’Malley, and Taranto. Appeal from the Patent Trial and Appeal Board. Summary: The Patent and Trademark Office’s October 2019 Revised Patent Subject Matter Eligibility Guidance cannot be used to modify…

April 24, 2020·Federal Circuit·2 min read
Federal Circuit

CHARGEPOINT, INC. v. SEMACONNECT, INC.

Federal Circuit Summary Before Prost , Reyna, and Taranto. Appeal from the U.S. District Court for the District of Maryland. Summary: An abstract idea cannot be used to supply an inventive concept that renders a claim “significantly more” than…

March 28, 2019·Federal Circuit·1 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.